Aldo Scarpa

88.3k total citations · 8 hit papers
609 papers, 32.9k citations indexed

About

Aldo Scarpa is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Aldo Scarpa has authored 609 papers receiving a total of 32.9k indexed citations (citations by other indexed papers that have themselves been cited), including 372 papers in Oncology, 169 papers in Molecular Biology and 165 papers in Epidemiology. Recurrent topics in Aldo Scarpa's work include Pancreatic and Hepatic Oncology Research (231 papers), Neuroendocrine Tumor Research Advances (141 papers) and Cancer Genomics and Diagnostics (90 papers). Aldo Scarpa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (231 papers), Neuroendocrine Tumor Research Advances (141 papers) and Cancer Genomics and Diagnostics (90 papers). Aldo Scarpa collaborates with scholars based in Italy, United States and United Kingdom. Aldo Scarpa's co-authors include Massimo Falconi, Giuseppe Zamboni, Paola Capelli, Carlo M. Croce, George A. Calin, Stefano Volinia, Claudio Luchini, Claudia Roldo, Chang‐Gong Liu and Manuela Ferracin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Aldo Scarpa

591 papers receiving 32.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A microRNA expression signature of human solid tumors defines cancer gene targets

2006 4.7k citations Stefano Volinia, George A. Calin et al. Proceedings of the National Academy of Sciences profile →
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

2006 1.2k citations Guido Rindi, Massimo Falconi et al. profile →
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

2007 693 citations Guido Rindi, Aldo Scarpa et al. profile →
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

2019 685 citations Claudio Luchini, Alessia Nottegar et al. profile →
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

2006 651 citations Claudia Roldo, Massimo Falconi et al. profile →
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis

2003 575 citations Aldo Scarpa, Claudio Doglioni et al. profile →
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Michèle Milella, Matteo Brunelli et al. profile →
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism

2023 138 citations Andrea Mafficini, Aldo Scarpa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aldo Scarpa Italy	77	17.2k	11.9k	9.5k	9.3k	5.3k	609	32.9k
Anirban Maitra United States	115	25.8k 1.5×	26.6k 2.2×	14.4k 1.5×	5.5k 0.6×	8.6k 1.6×	564	51.1k
Peter Schirmacher Germany	86	11.6k 0.7×	10.9k 0.9×	7.6k 0.8×	9.2k 1.0×	6.8k 1.3×	681	36.7k
Domenico Coppola United States	75	9.4k 0.5×	11.7k 1.0×	5.0k 0.5×	4.0k 0.4×	2.2k 0.4×	367	23.3k
Éric Raymond France	71	10.9k 0.6×	8.8k 0.7×	3.0k 0.3×	4.4k 0.5×	1.7k 0.3×	369	22.4k
Adel K. El‐Naggar United States	99	16.8k 1.0×	12.0k 1.0×	5.1k 0.5×	3.2k 0.3×	11.9k 2.2×	679	36.4k
Jessica Zucman‐Rossi France	82	7.2k 0.4×	13.9k 1.2×	7.8k 0.8×	6.4k 0.7×	4.6k 0.9×	322	31.8k
Yung‐Jue Bang South Korea	87	20.9k 1.2×	10.8k 0.9×	4.6k 0.5×	2.8k 0.3×	7.6k 1.4×	610	37.1k
Heikki Joensuu Finland	97	12.8k 0.7×	8.4k 0.7×	6.2k 0.7×	1.6k 0.2×	7.1k 1.3×	583	35.5k
Charles M. Rudin United States	86	15.7k 0.9×	17.2k 1.4×	4.6k 0.5×	6.4k 0.7×	1.3k 0.2×	458	31.1k
Nickolas Papadopoulos United States	65	11.7k 0.7×	13.1k 1.1×	10.6k 1.1×	2.1k 0.2×	2.7k 0.5×	164	28.1k

Countries citing papers authored by Aldo Scarpa

Since Specialization

Citations

This map shows the geographic impact of Aldo Scarpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Scarpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Scarpa more than expected).

Fields of papers citing papers by Aldo Scarpa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Scarpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Scarpa. The network helps show where Aldo Scarpa may publish in the future.

Co-authorship network of co-authors of Aldo Scarpa

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Scarpa. A scholar is included among the top collaborators of Aldo Scarpa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Scarpa. Aldo Scarpa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fassan, Matteo, Valentina Angerilli, Nicola Normanno, et al.. (2024). Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper. Critical Reviews in Oncology/Hematology. 194. 104224–104224. 8 indexed citations

Malleo, Giuseppe, Gabriella Lionetto, Stefano Crippa, et al.. (2024). Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery. 282(6). 1092–1101. 3 indexed citations

Alors‐Pérez, Emilia, Marina Sánchez‐Frías, Andrea Mafficini, et al.. (2024). The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma. Cancer Gene Therapy. 31(11). 1646–1657. 2 indexed citations

Mattiolo, Paola, Mario De Bellis, Andrea Mafficini, et al.. (2024). Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature. Journal of Gastrointestinal Cancer. 55(4). 1634–1646.

Mattiolo, Paola, Huamin Wang, Olca Baştürk, et al.. (2023). Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review. Journal of Clinical Pathology. 76(11). 740–746. 4 indexed citations

Maggino, Laura, Giuseppe Malleo, Stefano Crippa, et al.. (2023). Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy. British journal of surgery. 110(8). 973–982. 5 indexed citations

Marletta, Stefano, Vincenzo L’Imperio, Albino Eccher, et al.. (2023). Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases. Pathology - Research and Practice. 243. 154362–154362. 27 indexed citations

Γκουντάκος, Αναστάσιος, Giovanni Centonze, Emanuele Vita, et al.. (2022). Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines. 10(2). 277–277. 10 indexed citations

Simbolo, Michele, Andrea Mafficini, Claudio Luchini, et al.. (2021). Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades. Cancers. 13(9). 2054–2054. 18 indexed citations

10.

Fumagalli, Caterina, Elena Guerini‐Rocco, Fiamma Buttitta, et al.. (2020). Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network. Journal of Clinical Pathology. 74(10). 668–672. 3 indexed citations

11.

Robertis, Riccardo De, Chiara Longo, Sara Cingarlini, et al.. (2020). Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake. Cancers. 12(6). 1486–1486. 9 indexed citations

12.

Calabrese, Angela, Paola Capelli, Paolo Tinazzi Martini, et al.. (2019). Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study. Cancers. 11(2). 267–267. 16 indexed citations

13.

Ragulan, Chanthirika, Katherine Eason, Elisa Fontana, et al.. (2019). Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. Scientific Reports. 9(1). 7665–7665. 29 indexed citations

14.

Luchini, Claudio, Achim Fleischmann, Joost L. Boormans, et al.. (2017). Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis. Scientific Reports. 7(1). 2374–2374. 26 indexed citations

15.

Botla, Sandeep K., Soniya Savant, Pouria Jandaghi, et al.. (2016). Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression. Cancer Research. 76(14). 4149–4159. 67 indexed citations

16.

Sadanandam, Anguraj, Stephan Wullschleger, Costas A. Lyssiotis, et al.. (2015). A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. Cancer Discovery. 5(12). 1296–1313. 139 indexed citations

17.

Amato, Eliana, Marco Dal Molin, Andrea Mafficini, et al.. (2014). Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. The Journal of Pathology. 233(3). 217–227. 235 indexed citations

18.

Rosa, Roberta, Davide Melisi, Vincenzo Damiano, et al.. (2011). Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in K - Ras Mutant Colorectal and Pancreatic Cancers. Clinical Cancer Research. 17(20). 6531–6541. 44 indexed citations

19.

Balakrishnan, Asha, Fonnet E. Bleeker, Simona Lamba, et al.. (2007). Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma. Cancer Research. 67(8). 3545–3550. 128 indexed citations

20.

Volinia, Stefano, George A. Calin, Chang‐Gong Liu, et al.. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences. 103(7). 2257–2261. 4730 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact